+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CytImmune Sciences Inc - logo

CytImmune Sciences, Inc. operates as a clinical stage nanomedicine company that discovers, develops, and commercializes multifunctional tumor-targeted therapies. The company develops Aurimune, a nanomedicine platform that gets into the tumor and breaks down its defenses. It is engineered to travel safely and stealthily through the body and enter tumors through their most vulnerable points – the leaky blood vessels that make up the nutritional support structures. CytImmune Sciences, Inc. was founded in 1988 and is based in Rockville, Maryland.

From
From
From
Thyroid Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Thyroid Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 1074 pages
From
From
From
From
From
Nanomaterials in Personalized Medicine: Global Markets - Product Thumbnail Image

Nanomaterials in Personalized Medicine: Global Markets

  • Report
  • February 2021
  • 141 Pages
From
From
From
Pancreatic Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 4317 pages
From
From
From
From
  • 20 Results (Page 1 of 1)
Loading Indicator
adroll